68) A borderline significant reduction in mortality with the hydralazine/isosorbide nitrate combination compared to placebo was observed over the average 2.3 year follow-up period.
← all excerpts
Medical Management of Patients With Heart Failure and Reduced Ejection Fraction.
3
—
—
The sentences
There was, however, a highly significant 29% reduction in the development of HF in the enalapril group.
There were 34% fewer primary endpoints (death or need for transplant) in the metoprolol group, an effect of borderline significance.